Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Profound Medical (PROF) Shares Outstanding (Weighted Average) (2023 - 2025)

Profound Medical (PROF) has 3 years of Shares Outstanding (Weighted Average) data on record, last reported at $30.2 million in Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 22.08% year-over-year to $30.2 million; the TTM value through Dec 2025 reached $30.2 million, up 22.08%, while the annual FY2025 figure was $30.2 million, 22.08% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $30.2 million in Q4 2025 per PROF's latest filing, roughly flat from $30.1 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $30.2 million in Q4 2025 and bottomed at $21.2 million in Q4 2023.
  • Average Shares Outstanding (Weighted Average) over 3 years is $26.6 million, with a median of $24.8 million recorded in 2024.
  • Peak YoY movement for Shares Outstanding (Weighted Average): rose 16.91% in 2024, then increased 23.65% in 2025.
  • A 3-year view of Shares Outstanding (Weighted Average) shows it stood at $21.2 million in 2023, then grew by 16.91% to $24.8 million in 2024, then grew by 22.08% to $30.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $30.2 million in Q4 2025, $30.1 million in Q3 2025, and $30.1 million in Q2 2025.